Elix

active

Tokyo, Japan

Founded 2022

About

AI Drug Discovery

Areas of Focus

Categories

AI FocusedJapan

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

3

By Phase

NA: 1

By Status

TERMINATED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2000

2001

2002

2003

Today

Hover over trial bars to see details

Recent Trials

NCT00038818Collaborator

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Started: May 31, 2001 · Completed: Dec 31, 2002

Locations (1)

Headquarters

Tokyo, Japan

Map

Loading map...